NEWS - Porosome Therapeutics, Inc.

Editorial on the pioneering discovery of the porosome nearly 30-years ago and its current application in the development of novel therapeutics for the treatment and cure of a wide range of debilitating diseases, is published in the Discoveries Journal

Porosome Therapeutics, Inc., Chairman, Prof. Dr. Bhanu P. Jena and Chairman of the Scientific Advisory Board, Prof. Dr. Joachim Frank have been invited to participate at the Nobel Prize Dialogue being held in Seoul, South Korea on September 24th 2023.

Porosome Therapeutics, Inc. Files Comprehensive Patent for New Generation of Treatments for Cystic Fibrosis and Other Diseases

Porosome Therapeutics is the new name of Viron.

Endowed lectureship created at Wayne State University in the Department of Physiology, to recognize the pioneering scientific contributions of Prof. Bhanu P. Jena, Ph.D.

Prof. Joachim Frank is the new Chairman of the Scientific Advisory Board!

Professor Joachim Frank is a 2017 Nobel Laureate in Chemistry

VIRON LAUNCHES POROSOME RECONSTITUTION THERAPY & IDENTIFICATION OF THE COMBINATORIAL USE OF SMALL MOLECULES AS DRUGS TO TARGET ‘UNDRUGGABLE' POROSOME PROTEINS

Dr. Flic Gabbay, President FPM, UK, joins Viron Scientific Advisory Board

Dean Sten H. Vermund, MD, PhD joins the Viron Scientific Advisory Board

Prof. Simon C. Robson joins our Scientific Advisory Board!

From the CEO’s Desk

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray